Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genotype 1 hepatitis C virus and the pharmacist's role in treatment.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists - 1 Jun 2016

Sebhatu Phoebe, Martin Michelle T

Abstract excerpt

PURPOSE: The treatment of hepatitis C virus (HCV) genotype 1 has changed rapidly with recently approved direct-acting antiviral (DAA) regimens. The role of the pharmacist in the management of HCV therapy has increased. SUMMARY: Chronic HCV infection is the main cause of end-stage liver disease and the primary reason for liver transplantation, liver-related death, and hepatocellular carcinoma in the United States....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Drug Therapy, Combination

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Hepacivirus

Share to Hepatitis C, Chronic

Share to Hepatitis C virus research

Share to Treatment Outcome

Source

Identifiers

PMID: 27126832
DOI: 10.2146/ajhp150704

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genotype 1 hepatitis C virus and the pharmacist's role in treatment.PMID 27126832Read ↗

Pharmacist intervention in treatment of patients with genotype 1 chronic hepatitis C.Semantic proximity Read ↗

Diagnosis and Management of Hepatitis C Infection in Primary Care Settings.Semantic proximity Read ↗

Therapeutic approach to the treatment-naive patient with hepatitis C virus genotype 1 infection: a step-by-step approach.Semantic proximity Read ↗

Management of the treatment-experienced patient infected with hepatitis C virus genotype 1: options and considerations.Semantic proximity Read ↗

A survey of hepatitis C treatment clinical practice patterns using the newly approved protease inhibitors.Semantic proximity Read ↗

Pharmacology Update for the Treatment of Hepatitis C Virus.Semantic proximity Read ↗

Prevalence of drug-drug interactions with pangenotypic direct-acting antivirals for hepatitis C and real-world care management in the United States: a retrospective observational study.Semantic proximity Read ↗

Provisional guidance on the use of hepatitis C virus protease inhibitors for treatment of hepatitis C in HIV-infected persons.Semantic proximity Read ↗

Current and Evolving Treatments of Genotype 1 Hepatitis C Virus.Semantic proximity Read ↗

First-wave protease inhibitors for hepatitis C genotype 1 treatment: a real-life experience in Brazilian patients.Semantic proximity Read ↗

Protease inhibitors for the treatment of chronic hepatitis C genotype-1 infection: the new standard of care.Semantic proximity Read ↗

Protease inhibitors for treatment of genotype 1 hepatitis C virus infection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.